Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Enxiao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3909-211X; OpenAlex author ID A5102731988. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers

Papers 3

  1. Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer. Co-author DOI 10.1016/j.jncc.2022.08.006↗
  2. Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma. Last author DOI 10.4251/wjgo.v14.i7.1252↗
  3. Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways. Co-author DOI 10.21037/tcr-21-207↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuan Hu · 2 shared papers, 2021–2022 · strength 0.26
  2. Yangwei Fan · 1 shared paper, 2021 · strength 0.13
  3. Xi Wang · 1 shared paper, 2022 · strength 0.12
  4. Baojun Duan · 1 shared paper, 2022 · strength 0.12
  5. Feng Jiao · 1 shared paper, 2022 · strength 0.09
  6. Zheng Wang · 1 shared paper, 2022 · strength 0.09
  7. Zhiwei Li · 1 shared paper, 2022 · strength 0.09
  8. Tao Zhang · 1 shared paper, 2022 · strength 0.09
  9. Qingyong Ma · 1 shared paper, 2022 · strength 0.09
  10. Liwei Wang · 1 shared paper, 2022 · strength 0.09
  11. Chunyi Hao · 1 shared paper, 2022 · strength 0.09
  12. Gang Ren · 1 shared paper, 2022 · strength 0.09
  13. Jie Chen · 1 shared paper, 2022 · strength 0.09
  14. Dan Cao · 1 shared paper, 2022 · strength 0.09
  15. Jian Wang · 1 shared paper, 2022 · strength 0.09
  16. Yongrui Bai · 1 shared paper, 2022 · strength 0.09
  17. Zhihong Zhang · 1 shared paper, 2022 · strength 0.09
  18. Yongwei Sun · 1 shared paper, 2022 · strength 0.09
  19. Ji Li · 1 shared paper, 2022 · strength 0.09
  20. Jianping Xiong · 1 shared paper, 2022 · strength 0.09
  21. Jun Zhou · 1 shared paper, 2022 · strength 0.09
  22. Feng‐Hua Wang · 1 shared paper, 2022 · strength 0.09
  23. Leizhen Zheng · 1 shared paper, 2022 · strength 0.09
  24. Da Li · 1 shared paper, 2022 · strength 0.09
  25. Chengfeng Wang · 1 shared paper, 2022 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.